World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 65 2817 2598 1332 1220 191 18285

Peter Kufer publications per year

The chart shows the history of publications by Peter Kufer between 1992 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Peter Kufer published across 32 years, from 1992 to 2023, averaging 9.8 papers a year. Output peaked at 55 publications in 2023. 56 of the 313 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1992 to 2023. Vertical axis: number of publications, 0 to 55. Peak 55 publications in 2023. 1992: 1 publication 1993: 0 publications 1994: 0 publications 1995: 3 publications 1996: 1 publication 1997: 4 publications 1998: 9 publications 1999: 7 publications 2000: 4 publications 2001: 4 publications 2002: 4 publications 2003: 4 publications 2004: 12 publications 2005: 9 publications 2006: 29 publications 2007: 12 publications 2008: 18 publications 2009: 22 publications 2010: 19 publications 2011: 5 publications 2012: 14 publications 2013: 9 publications 2014: 12 publications 2015: 5 publications 2016: 15 publications 2017: 17 publications 2018: 4 publications 2019: 6 publications 2020: 4 publications 2021: 4 publications 2022: 1 publication 2023: 55 publications
1992 2023

313 publications in total across all disciplines

View publications per year as a table
Peter Kufer: publications per year, 1992 to 2023
Year Publications
1992 1
1993 0
1994 0
1995 3
1996 1
1997 4
1998 9
1999 7
2000 4
2001 4
2002 4
2003 4
2004 12
2005 9
2006 29
2007 12
2008 18
2009 22
2010 19
2011 5
2012 14
2013 9
2014 12
2015 5
2016 15
2017 17
2018 4
2019 6
2020 4
2021 4
2022 1
2023 55
Total 313
Download as CSV

Peter Kufer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter Kufer sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 182–191 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 191 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188 191
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Peter Kufer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Kufer sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 64–65 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173 65
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Peter Kufer is affiliated with Amgen in the United States and works primarily in the field of Medicine, with a focus on Oncology. Their research encompasses several subfields including Radiology, Nuclear Medicine and Imaging, Biomedical Engineering, Immunology, and Pulmonary and Respiratory Medicine.

Their work centers on key topics such as CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Radiopharmaceutical Chemistry and Applications, Nanowire Synthesis and Applications, and Nanofabrication and Lithography Techniques.

Among their frequent co-authors are Sabine Stienen, Gerhard Zugmaier, Maria-Elisabeth Goebeler, Ralf C. Bargou, and Joachim Wahl.

Peter Kufer has published in several notable journals including Cancer, Cancer Research, Immunotherapy, Clinical Cancer Research, and the Journal of Clinical Oncology.

  • "The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types," 2020, Cancer
  • "Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings," 2020, Immunotherapy
  • "The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer," 2021, Clinical Cancer Research
  • "Phase I study of pasotuxizumab (AMG 212/BAY 2010112), a PSMA-targeting BiTE (Bispecific T-cell Engager) immune therapy for metastatic castration-resistant prostate cancer (mCRPC)," 2020, Journal of Clinical Oncology
  • "Abstract ND06: AMG 305, a dual targeting BiTE®molecule with selective activity for solid tumors that co-express CDH3 and MSLN," 2023, Cancer Research

Best Publications

  • Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

    Ralf Bargou;Eugen Leo;Gerhard Zugmaier;Matthias Klinger

  • Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

    Max S. Topp;Peter Kufer;Nicola Gökbuget;Mariele Goebeler

  • A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity

    Matthias Mack;Gert Riethmuller;Peter Kufer

  • A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

    Anja Löffler;Peter Kufer;Peter Kufer;Peter Kufer;Ralf Lutterbüse;Ralf Lutterbüse;Ralf Lutterbüse;Florian Zettl;Florian Zettl;Florian Zettl

  • Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.

    Matthias Klinger;Christian Brandl;Gerhard Zugmaier;Youssef Hijazi

  • Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

    Max S. Topp;Nicola Gökbuget;Gerhard Zugmaier;Evelyn Degenhard

  • Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody

    Torsten Dreier;Grit Lorenczewski;Christian Brandl;Patrick Hoffmann

  • Novel method for the production of anti-human antigen receptors and uses thereof

    Peter Kufer;Tobias Raum

  • Blinatumomab: a historical perspective.

    Dirk Nagorsen;Peter Kufer;Patrick A. Baeuerle;Ralf Bargou

  • Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.

    Sonja Offner;Robert Hofmeister;Andrea Romaniuk;Peter Kufer

  • Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

    Maria-Elisabeth Goebeler;Stefan Knop;Andreas Viardot;Peter Kufer

  • BiTEs: bispecific antibody constructs with unique anti-tumor activity.

    Evelyn Wolf;Robert Hofmeister;Peter Kufer;Bernd Schlereth

  • MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors.

    Klaus Brischwein;Bernd Schlereth;Benjamin Guller;Carola Steiger

  • CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF

    Bernd Dorken;Gert Riethmuller;Peter Kufer;Ralf Lutterbuse

  • Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.

    A Zippelius;P Kufer;G Honold;M W Köllermann

  • A revival of bispecific antibodies

    Peter Kufer;Ralf Lutterbüse;Patrick A. Baeuerle

  • Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen

    Claudia Bluemel;Susanne Hausmann;Petra Fluhr;Mirnalini Sriskandarajah

  • T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct

    Torsten Dreier;Patrick A. Baeuerle;Iduna Fichtner;Michael Grün

  • T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

    Ralf Lutterbuese;Tobias Raum;Roman Kischel;Patrick Hoffmann

  • BiTE: Teaching antibodies to engage T-cells for cancer therapy.

    Patrick A Baeuerle;Peter Kufer;Ralf Bargou

Frequent Co-Authors

Patrick A. Baeuerle
Patrick A. Baeuerle Cullinan Oncology, Inc.
Gert Riethmüller
Gert Riethmüller Ludwig-Maximilians-Universität München
Matthias G. Friedrich
Matthias G. Friedrich McGill University
Hermann Einsele
Hermann Einsele University of Würzburg
Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Andreas Wolf
Andreas Wolf Max Planck Society
Peter A. Kiener
Peter A. Kiener AstraZeneca (United Kingdom)
Andreas Mackensen
Andreas Mackensen University of Erlangen-Nuremberg
Oliver G. Ottmann
Oliver G. Ottmann Cardiff University
Dieter Hoelzer
Dieter Hoelzer Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology, pursuing related healthcare degrees online can be a strategic move. Many professionals in this field explore nursing pathways that complement their scientific expertise. An accelerated nurse practitioner program offers a fast-tracked route to becoming a nurse practitioner, providing essential clinical skills and advanced knowledge for patient care.

Transitioning within nursing specialties is also common. For example, acute care certification for FNP (Family Nurse Practitioner) holders enables them to focus on critical care settings, broadening their scope and job opportunities in healthcare environments requiring specialized skills.

Additionally, those new to healthcare can enroll in online accelerated nursing programs for non nurses. These programs help individuals without a nursing background enter the field efficiently while gaining the necessary credentials.

Salary considerations are important when selecting a degree path. Exploring the average doctorate in nursing salary by state can help candidates understand earning potentials across different locations, guiding informed decisions about education and career development.

By leveraging these online degree options and certifications, students can build versatile skill sets that intersect with immunology, enhancing their contributions to healthcare and research.

Learn more about these pathways through the following resources:

Best Scientists Citing Peter Kufer

Trending Scientists

Recently Published Articles